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The aim of this study was to determine the effects of subchronic
exposure to complex mixtures of polyhalogenated aromatic hydro-
carbons (PHAHs) on the thyroid hormone and retinoid status in
female Sprague-Dawley rats and to investigate the predictability
of these effects by the toxic equivalency factor (TEF) concept. In
the first experiment, the focus was on a complex dioxin-like PHAH
mixture, which covered > 90% of the total toxic equivalents (TEQ)
present in Baltic herring. In the second experiment, the contribu-
tion of non-dioxin-like polychlorinated biphenyls (PCBs) was in-
vestigated by testing the commercial PCB mixture Aroclor 1260,
its 0-1 ortho and 2-4 ortho fractions and the reconstituted 0-4
ortho fraction. Hepatic retinoid levels were severely decreased
(;70%) after treatment with the dioxin-like PHAH mixture, sim-
ilar to the effect of a TEQ equivalent dose of 1 mg 2,3,7,8-
TCDD/kg bw/week. However, the TEF concept failed to predict
the effect on plasma retinol; a decrease (21%) was observed after
treatment with the PHAH mixture, whereas an increase (21%) was
found after treatment with TCDD. A more severe decrease of total
thyroid hormone in plasma was observed after exposure to the
PHAH mixture compared to treatment with TCDD (;60% vs.
38%). The discrepancy found between the predicted and observed
effects for plasma retinol and thyroid hormone is possibly due to
an additional effect of hydroxylated PCBs, formed from metabo-
lizable PCBs present in the PHAH mixture. Aroclor 1260 and its
fractions did not significantly alter the retinoid and thyroid hor-
mone status at the dose levels tested, indicating that in case of
exposure to complex PCB mixtures at environmental levels, no
effects, or at best, only marginal effects can be expected on the
retinoid and thyroid hormone status.
Key Words: PCBs; dioxins; TCDD; mixtures; vitamin A; thyroid
hormone; subchronic; rat.
Polychlorinated biphenyls (PCBs), polychlorodibenzo-p-di-
oxins (PCDDs), polychlorinated dibenzofurans (PCDFs), and
other polyhalogenated aromatic hydrocarbons (PHAHs) elicit a
broad spectrum of toxic effects and biochemical changes, e.g.,
body weight loss, thymic atrophy, hepatotoxicity, carcinoge-
nicity, induction of hepatic cytochrome P450 isoenzymes, and
alterations of the retinoid status and thyroid hormone metabo-
lism (Safe, 1990, 1994).
Most, if not all, of the toxic responses of PHAHs are
suggested to be mediated by the aryl hydrocarbon (Ah) recep-
tor (Ahlborg et al., 1994; Safe, 1994). The most toxic PHAH
compounds exhibit a planar molecular conformation with lat-
eral chlorine substitution, thereby expressing a so-called diox-
in-like toxicity. Di-ortho substituted PCBs are in general less
toxic; due to their nonplanar conformation, they do not exhibit
Ah-receptor agonistic activity, but have been shown to possess
a phenobarbital-like toxicity (Safe, 1994).
In environmental matrices and biota PCBs, PCDDs, and
PCDFs are always present as complex mixtures. The toxic
equivalency factor (TEF) concept has been developed to aid
the risk assessment of complex mixtures of PHAHs. Based
on in vivo and in vitro studies, the relative toxic potencies of
individual PHAHs have been determined relative to 2,3,7,8-
TCDD as the most toxic congener. The TEF concept is
based on the assumptions that all non-ortho and mono-ortho
chlorine substituted PCB congeners and related dibenzo-p-
dioxins and dibenzofurans act through the Ah receptor-
based mechanism of action and that the effects of the
individual compounds in a mixture, expressed as toxic
equivalencies (TEQs), are additive (Ahlborg et al., 1994;
Safe, 1990, 1994). However, interactive effects have been
observed between PHAHs and some nonplanar di-ortho
PCB congeners or PCB mixtures (Aarts et al, 1995; Bager et
al., 1995; Biegel et al, 1989; Davis and Safe, 1989; Haag-
Gro¨nlund et al., 1998; Sargent et al., 1991; Yao and Safe,
1989; Zhao et al., 1994). In addition, several di-ortho PCBs
have been shown to possess toxic properties both in vivo and
in vitro, e.g., disturbance of the vitamin A and thyroid
hormone status, development of altered hepatic foci, and
inhibition of intercellular communication (Bager et al.,
1997; van Birgelen et al., 1992; de Haan et al., 1995).
Several toxicity studies have been performed with com-
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plex PCB mixtures (Abraham et al., 1989; Ahlborg et al.,
1987; Kihlstro¨m et al., 1992; Kimbrough et al., 1975; Morse
et al., 1996; Ward, 1985). However, in most studies the
focus was on individual PHAH congeners or combinations
of two or three congeners (Bager et al., 1995; van Birgelen
et al., 1994a,b; Haag-Gro¨nlund et al., 1998; Sargent et al.,
1991). Our major aim of this study was to evaluate the
applicability of the TEF concept for the tumor promotion
potential of complex environmentally relevant PHAH mix-
tures (van der Plas et al., 1999, 2000). In addition, the
effects of subchronic exposure to these PHAH mixtures was
determined on endocrine parameters, in particular on the
vitamin A and thyroid hormone system. Vitamin A and
thyroid hormone are both essential for normal tissue growth,
differentiation, and fetal development, and are possibly in-
volved in carcinogenesis (Blomhoff, 1994; Dunn, 1989;
Guernsey, 1993).
Alterations in both vitamin A and thyroid hormone levels are
a well-known effect of PHAHs in rodents following single-
dose or subchronic treatment (van Birgelen et al., 1992,
1994a,b, 1995; Brouwer et al., 1988b; Chen et al., 1992). In
short, retinol and thyroxine (T4) were both reduced in rat
plasma following exposure to metabolizable planar (PCB 77),
mono-, and di-ortho PCBs (Brouwer et al. 1988a; Morse et al.
1996). However, TCDD and relatively stable PCBs (PCB 126,
169, 156) were found to increase plasma retinol, whereas T4
was still reduced (van Birgelen 1994a,b, 1995). The reasons for
the effects of PHAHs on plasma levels of retinol and T4 are
partly due to direct effects of hydroxylated PHAH metabolites
on the plasma transport protein complex of T4 and retinol
(Brouwer and van den Berg, 1986; Brouwer et al., 1988a,b);
effects on hepatic metabolism of T4 and retinol by parent
compounds, i.e., mainly increased T4 glucuronidation; and
reduced formation of retinyl esters and retinol metabolism
(Brouwer et al., 1998; Zile, 1992).
In this manuscript, the effects on vitamin A and thyroid
hormone status in female Sprague-Dawley rats was studied
after subchronic exposure to complex PHAH mixtures. The
possible interactive effects between congeners and the involve-
ment of different mechanisms are discussed. Data were ob-
tained from two independent experiments. In the first experi-
ment, the focus was on a complex synthetic mixture of dioxin-
like, planar compounds and possible interactive effects with
the non-dioxin-like PCB 153 (2,29,4,49,5,59-HxCB). The com-
position of this mixture was based on the presence and relative
ratios of PHAH in fish, one of the main contributors of PHAHs
to the human diet. In the second experiment, the main focus
was on complex mixtures containing only di-ortho PCBs, or
planar (non- and mono-ortho) PCBs. These mixtures were
obtained by fractionation of the commercial PCB mixture
Aroclor 1260. The planar and di-ortho PCBs were tested
individually and after reconstitution.
MATERIALS AND METHODS
Chemicals. N-nitrosodiethylamine (NDEA) was obtained from Fluka
(Fluka Chemie, Buchs, Switzerland); 3,39,4,49,5-pentachlorobiphenyl (PCB
126), 2,39,4,49,5-pentachlorobiphenyl (PCB 118), 2,3,39,4,49,5-hexachlorobi-
phenyl (PCB 156), and 2,29,4,49,5,59-hexachlorobiphenyl (PCB 153) were
kindly provided by Prof. Å. Bergman (Department of Environmental Chem-
istry, Stockholm University, Sweden). 1,2,3,7,8-Pentachlorodibenzo-p-dioxin
(PeCDD) was obtained from Wellington Laboratories (Canada), 2,3,4,7,8-
pentachlorodibenzofuran (PeCDF) was a gift from Prof. S. H. Safe (College of
Veterinary Physiology and Pharmacology, Texas A&M University, USA), and
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) was purchased from RADIAN
CIL, Inc.(USA). All compounds had a purity . 99%. Aroclor 1260 was kindly
provided by Dr. M. van den Berg (Research Institute of Toxicology, University
of Utrecht, The Netherlands).
Retinoid standards (retinol, retinyl palmitate, and retinyl acetate) were all
obtained from Fluka Chemie (Sigma-Aldrich Chemie BV, Zwijndrecht, The
Netherlands). Amerlite chemiluminescence assay kits for thyroid hormone
analysis were obtained from Ortho-Clinical Diagnostics (Amersham, UK).
All other compounds were of analytical grade.
Animal experiments. Two subchronic animal experiments were per-
formed, both approved by the animal welfare committee before starting the
experiments. The treatment protocol used for these experiments was based on
the altered hepatic foci (AHF) tumor promotion protocol introduced by Pitot et
al. (1978) and described in detail by van der Plas et al. (1999, 2000). In short,
an initiation step, consisting of a diethylnitrosamine injection (i.p. 30 mg/kg
body weight) 24 h after a partial (two-thirds) hepatectomy, is followed by a
promotion treatment of 20 weeks starting 6 weeks after the hepatectomy.
For these experiments, juvenile female Sprague-Dawley rats (Møllegaard
Breeding Center Ltd., Denmark) about 6 weeks of age at the start of the
experiment were used. The rats were kept in wire-bottom, stainless steel cages
in groups of four animals under standard conditions (12 h light/dark cycle,
temperature 22°C, humidity 55%) and fed ad libitum (pellets, Hope Farms
Woerden). Test compounds were administered once a week by subcutaneous
injections for 20 weeks at concentrations indicated in Table 1. A corn oil group
(1 ml/kg bw/week) as a negative vehicle control and a TCDD group (1 mg/kg
body weight/week) as a positive control were incorporated in both experi-
ments. The first dose was a loading dose, which was five times the concen-
tration of the maintenance dose given for the following 19 weeks.
One week after the last injection, the animals were sacrificed under ether
anesthesia, using orbital puncture for blood collection (heparinized), followed
by decapitation. The liver was collected, of which a part was stored at –80°C
for gas chromatography and mass spectrometry (GC-MS) analysis and a part
was placed in formaldehyde and acetone fixative for immunohistochemistry
purposes. The rest of the liver was homogenized on ice in a Potter tube with
0.01 M Tris–HCl-buffer and 0.25 M sucrose (pH 7.4). Plasma was collected by
centrifugation of the blood at 500 3 g for 10 min.
PHAH exposure mixtures. Two different environmentally relevant
PHAH mixtures were tested in separate subchronic animal experiments in
groups and concentrations as presented in Table 1.
The composition of the PHAH mixtures tested in experiment 1 was based on
PHAH contamination found in Baltic herring and covered over 90% of the
TEQs present in these fish. The PHAH mixture contained the following
congeners: 2,3,7,8-TCDD; 1,2,3,7,8-PeCDD; 2,3,4,7,8-PeCDF; PCB 126;
PCB 118; PCB 156; and PCB 153, in relative ratios indicated in Table 2. In
order to investigate possible interactive effects between planar and nonplanar
congeners, the mixture was also tested without the non-dioxin-like PCB 153.
In addition to the PHAH mixtures, the commercial PCB mixture Aroclor 1254
was tested. The PHAH mixture containing solely dioxin-like PHAHs is re-
ferred to as PHAH–; the mixture including PCB 153 is referred to as PHAH1.
A more detailed description of the mixture preparation and the experimental
setup is given in van der Plas et al. (1999). Calculation of the TEQs of the
PHAH mixtures was based on TEF values as proposed by the WHO (Ahlborg
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et al., 1994) and relative potency (REP) values obtained from tumor promotion
studies (Hemming et al., 1993, 1995; Wærn et al., 1991).
In experiment 2, the focus was on the non-dioxin-like di- to tetra-ortho
substituted PCBs. For that purpose the commercial PCB mixture Aroclor 1260
was chosen as the experimental mixture, as approximately 90% of Aroclor
1260 consists of non-dioxin-like congeners. Aroclor 1260 was fractionated into
a 0-1 ortho dioxin-like fraction (;9.7 % of the total mass) containing mainly
0- and 1-ortho substituted PCBs and a trace of 2-ortho PCBs, and a 2-4 ortho
non-dioxin-like fraction (;90% of the total mass). This was done according to
a method described by Athanasiadou et al. (1991), with slight modifications
described in more detail by van der Plas et al. (2000). The 0-1 ortho fraction
and the 2-4 ortho fraction were tested separately and as a reconstituted 0-4
ortho mixture. Aroclor 1260 and PCB 153 were incorporated as an extra
positive control and a model compound for the di-ortho PCBs, respectively.
The composition of PCB congeners in the various fractions was tested by
GC-MS analysis and confirmed that no 2-4 ortho PCBs were present in the 0-1
ortho fraction (van der Plas et al., 2000). The TEQs of the Aroclor 1260
fractions were determined using the DRE-CALUX bio-assay (van der Plas et
al., 2000).
Vitamin A analysis. Retinol levels were measured in plasma and retinol
and retinyl palmitate levels in liver homogenates according to Brouwer et
al. (1989) with some modifications. Plasma, or liver homogenate (50 ml)
was extracted with methanol containing 0.1% BHT as an antioxidant and an
internal standard (0.5 mg retinyl acetate/ml for plasma, 1 mg retinyl
acetate/ml for liver homogenate), and diisopropyl ether in a 1:1:2 concen-
tration. Samples were vortexed for 30 sec., kept overnight at –20°C,
vortexed again, and centrifuged for 10 min at 5000 rpm in an Eppendorf
centrifuge. The diisopropyl-ether phase was collected and filtered over a
0.45-mm filter (Millipore, Etten Leur, The Netherlands), evaporated under
N2, and resuspended in 50 ml methanol (plasma extracts) or 200 ml 1:3
ethylacetate/methanol (liver extracts) with 0.1% BHT. Extractions were
carried out in duplicate. Extraction efficiencies were routinely above 80%.
Twenty-microliter aliquots of resuspended extracts were analyzed with
HPLC using a C18 analytical reverse-phase column (Pecosphere, 3 mm
particle size, 3.3 cm length, and 4.6 mm internal diameter, Perkin Elmer)
and a wavelength of 326 nm for detection of retinoids. A Merck-Hitachi
HPLC system was used consisting of an L-6200 Intelligent pump, L-4200
UV-VIS detector, AS-2000 Autosampler, and a D-2500 Chromato Integra-
tor. Plasma extracts were analyzed isocratically with 86% methanol and
14% water with a flow rate of 1 ml/min and data collection for 10 min.
Hepatic retinoids were analyzed by 86% methanol and 14% water for 1.5
min, followed by a gradient to 100% methanol for 2.5 min, and subsequent
elution of the retinyl esters for 12 min. The column was then re-equilibrated
at 86% methanol and 14% water for 6 min.
Plasma thyroid hormone analysis. Total thyroxine (TT4), total triiodo-
thyronine (T3) and free thyroxin (FT4) levels were determined in plasma
using commercially available chemiluminescence kits, according to the
protocol of the supplier with the following modifications: the T4 assay
buffer was diluted five times in demineralized water. The standard curve for
TT4 ranged from 0 to 120 nmol/liter, for T3 from 0 to 6 nmol/liter, and for
FT4 from 0 to 106 pmol/liter. Thyroid hormone levels were calculated from
the luminescence data with the Elia-Securia II software program of Can-
berra Packerd.
Statistical analysis. Data were analyzed with the statistical package
SPSS-PC 7.5. A Tukey’s Honestly Significant Difference test was used to
perform a multiple comparison on statistical differences between groups.
TABLE 1
Dose Levels of the PHAH Mixtures and Aroclor 1260 Fractions Used in the Animal Studies
Mixture (Experiment) Group size n Dose/kg bw/week
Equivalent to Aroclor 1260
Amount (mg)
Toxic equivalency
(TEQ/kg bw/week)
Corn oil (1,2) 18 1 ml — No activity
2,3,7,8-TCDD (1,2) 12, 10 1 mg — 1 mg
PHAH1 mixture (1) 12 1.1 mg — 0.5 mga
2.3 mg — 1 mga
4.5 mg — 2 mga
PHAH–mixture (1) 12 1.0 mg — 1 mga
0–1 ortho fraction (2) 10 1 mg 10 1.1 ngb
2–4 ortho fraction (2) 10 1 mg 1.1 No activityb
3 mg 3.3 No activityb
9 mg 10 No activityb
0–4 ortho fraction (2) 10 10 mg 10 1.1 ngb
Aroclor 1254 (1) 12 7.5 mg — 0.2 mgc
Aroclor 1260 (2) 10 10 mg 10 1.3 ngb
a TEQ values based on literature data (see van der Plas et al., 1999).
b TEQ values determined using the DRE-CALUX assay (van der Plas et al., submitted).
c TEQ value based on WHO TEF values (van den Berg et al., 1998) and PCB concentrations in Aroclor 1254 (Leonards et al., 1995).
TABLE 2
Congener Composition of the PHAH Mixtures of Experiment 1
Congener
Relative level (weight base)
PHAH 2 mixture
– PCB 153
PHAH 1 mixture
1 PCB 153
2,3,7,8-TCDD 1 1
1,2,3,7,8-PeCDD 3.3 3.3
2,3,4,7,8-PeCDF 17 17
PCB 126 61 61
PCB 118 12800 12800
PCB 156 1888 1888
PCB 153 — 20000
Note. The composition of the mixtures is based on Swedish herring oil and
covers over 90% of the TEQs in Swedish herring.
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RESULTS
Vitamin A Levels
Experiment 1 (Table 3). Plasma retinol levels were signif-
icantly increased by 21% in the TCDD treatment group com-
pared to the corn oil group. In contrast, significantly decreased
plasma retinol levels were observed for all dioxin-like PHAH
mixture groups as well as for Aroclor 1254. A dose-dependent
decrease up to 32% reduction was observed in the groups
treated with the PHAH1 mixture. The largest decrease in
plasma retinol was found after treatment with Aroclor 1254
(38%), which is interesting, as in this group no significant
effects were observed on the hepatic retinyl palmitate levels. In
all other treatment groups, hepatic retinyl palmitate levels were
strongly decreased (60–80%) as compared to the corn oil
control group. The lowest dose of the PHAH1 mixture, 0.5 mg
TEQ/kg/week (’70 ng TEQ/kg bw/day), still gave rise to
significant plasma retinol and, in particular, hepatic retinyl
palmitate reductions, indicating that this is a very sensitive
response of the PHAH mixture. Retinol levels in the liver were
not affected in the PHAH treatment groups compared to the
corn oil group. As a consequence, the retinol/retinyl palmitate
ratios were increased in all treatment groups as compared to
corn oil controls.
Experiment 2 (Table 4). Similar to results from the first
experiment, the plasma retinol level was significantly increased
TABLE 3
Retinoid Levels in Plasma and Liver Tissue of Female Sprague-Dawley Rats Following Subchronic Exposure
to Dioxin-like PHAHs (Experiment 1)
Treatment
Dose/kg bw/week
Retinol in
plasma
(ng/ml)
Retinol in
liver tissue
(mg/g liver)
Retinyl palmitate
in liver tissue
(mg/g liver)
Retinol/retinyl
palmitate
(mg/mg)
Corn oil 1 ml 172.3 6 6.8a 4.75 6 0.33 1402.8 6 43.6a 3.5 6 0.3
TCDD 1 mg 208.3 6 12.4b 3.63 6 0.44 357.4 6 17.7b 10.4 6 1.4
Aroclor 1254 7.5 mg 106.8 6 5.5a,b 5.67 6 0.55 1258.4 6 51.7a 4.8 6 0.5
PHAH– 1 mg TEQ 124.3 6 6.5a,b 3.37 6 0.32 471.6 6 20.8a,b 7.3 6 0.7
PHAH1 0.5 mg TEQ 155.9 6 8.1a 4.06 6 0.43 569.9 6 37.4b 7.4 6 0.9
PHAH1 1 mg TEQ 136.6 6 11.2a,b 4.04 6 0.87 436.9 6 16.1a,b 9.1 6 1.8
PHAH1 2 mg TEQ 117.1 6 9.2b 3.50 6 0.40 303.4 6 16.2a,b 11.5 6 1.0
Note. Data are given as arithmetic mean 6 the standard error. Doses are given per kg bodyweight per week.
a Significantly different from the TCDD group ( p , 0.05 Tukey HSD test).
b Significantly different from the corn oil group ( p , 0.05 Tukey HSD test).
TABLE 4
Retinoid Levels in Plasma and Liver Tissue of Female Sprague-Dawley Rats Following Subchronic Exposure
to Non-dioxin and Dioxin-like Fractions of Aroclor 1260 (Experiment 2)
Treatment
Dose/kg bw/week
Retinol in
plasma
(ng/ml)
Retinol in
liver tissue
(mg/g liver)
Retinyl palmitate
in liver tissue
(mg/g liver)
Retinol/retinyl
palmitate
(mg/mg)
Untreated — 176.6 6 6.9 8.22 6 0.86 2052.3 6 111.3 4.0 6 0.3
Corn oil 1 ml 171.7 6 6.6 7.37 6 0.73 1733.1 6 70.4 4.2 6 0.4
TCDD 1 mg 223.1 6 16.0a 4.05 6 0.39a 474.5 6 32.0a 9.1 6 1.3a
Aroclor 1260 10 mg 162.1 6 6.6 4.65 6 0.31 1280.8 6 46.3a 3.7 6 0.3
0–4 ortho 10 mg 167.0 6 6.3 5.73 6 0.68 1400.0 6 62.3 4.1 6 0.5
0–1 ortho 1 mg 143.4 6 9.9 6.72 6 0.76 1731.5 6 175.7 4.1 6 0.6
2–4 ortho 1 mg 177.3 6 11.8 5.58 6 0.72 1688.6 6 71.9 3.3 6 0.4
2–4 ortho 3 mg 168.3 6 12.7 4.59 6 0.43 1529.2 6 64.3 3.0 6 0.2
2–4 ortho 9 mg 174.0 6 11.0 5.14 6 0.58 1476.1 6 66.9 3.5 6 0.4
PCB 153 1 mg 168.4 6 8.6 6.04 6 0.85 1770.4 6 89.8 3.4 6 0.4
PCB 153 9 mg 184.6 6 12.6 4.56 6 0.71 1233.9 6 77.0a 3.6 6 0.5
Note. Data are given as arithmetic mean 6 the standard error. Doses are given per kilogram bodyweight per week. 2–4 ortho 5 2–4 ortho substituted PCB
fraction of Aroclor 1260; 0–1 ortho 5 0–1 ortho substituted PCB fraction of Aroclor 1260 with a trace of 2 ortho substituted PCBs; 0–4 ortho 5 the
reconstituted mixture of the 2–4 and the 0–1 ortho fraction.
a Significantly different from the corn oil group ( p , 0.05 Tukey HSD test).
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in the TCDD treatment group (by 30%) compared to the corn
oil control group. However, no significant changes in plasma
retinol levels were observed after exposure to any of the PCB
fractions, Aroclor 1260, or PCB 153. Hepatic retinoid levels in
the corn oil group were slightly but nonsignificantly lower
compared to the untreated control group. Analysis of the he-
patic ethoxyresorufin-O-deethylase activity (van der Plas et al.,
in press) and luciferase induction by hepatic microsomes (un-
published results) in the AhR-dependent H4IIE-Luc reporter
gene (DRE-CALUX) assay did not indicate that this may be
due to a PHAH contamination of the corn oil. Therefore it is
concluded that the observed difference between the untreated
and the corn oi1 group in hepatic retinoid levels is more likely
related to the treatment procedure. In the group treated with
TCDD, the hepatic retinyl palmitate level was significantly
decreased to 55% of the corn oil control group. Aroclor 1260
and PCB 153, 9 mg/kg bw/week, also significantly decreased
the hepatic retinyl palmitate levels to 62% of the corn oil
group. The Aroclor 1260 fractions and PCB 153, 1 mg/kg
bw/week, did not affect retinyl palmitate levels in the liver
significantly, although there was a tendency for a dose-depen-
dent reduction in the 2-4 ortho fraction. Retinol levels in the
liver after PCB exposure were all nonsignificantly decreased
compared to the corn oil control. Except for TCDD, none of the
PHAH compounds changed the hepatic retinol/retinyl palmi-
tate ratio.
Thyroid Hormone Levels
Experiment 1 (Table 5). A small, statistically nonsignifi-
cant decrease was observed in the total plasma T3 levels after
PHAH treatment compared to the corn oil control. However,
plasma total and free T4 levels were decreased in most PHAH
treatment groups. A dose-dependent decrease of the total T4
levels compared to the corn oil group was observed after
treatment with different doses of the PHAH1 mixture up to
76% reduction in the highest dose of 2 mg TEQ/kg bw/week.
At the lowest dose of 0.5 mg TEQ/kg bw/week of the PHAH1
mixture, the plasma total T4 level was still reduced by .50%
as compared to corn oil controls. The total T4 level was much
less reduced (38%) after exposure to 1 mg/kg bw/week TCDD
as compared to the TEQ equivalent dose of the PHAH1
mixture. Free T4 levels were decreased in all treatment groups,
but the ratio of total T4 over free T4 (illustrating the effect on
the T4 fraction bound to its transport protein TTR) differed
between the treatment groups. The total T4/free T4 ratio was
not changed in the TCDD exposure group compared to the corn
oil control. However, a dose-dependent decrease of the total
T4/free T4 ratio was observed for the PHAH mixture groups.
Although the PHAH– and PHAH1 group at 1 mg TEQ/kg
bw/week are equipotent in theory, the effects on T3 and T4
levels were stronger in the latter.
Experiment 2 (data not shown). No changes were found in
thyroid hormone levels after exposure to Aroclor 1260, any of
its fractions, or PCB 153. A slight, nonsignificant decrease in
total T4 was observed after treatment with TCDD. The total
T4/free T4 ratio was significantly decreased (24%) after treat-
ment with the 0-4 ortho fraction.
DISCUSSION
The effects on endocrine parameters, i.e., thyroid hormone
and retinoid status, by complex mixtures of PHAHs are part of
a larger study aimed at investigating the predictability of sub-
chronic effects, as tumor promotion and biochemical effects,
by the TEF concept. The focus in this paper is on the impact of
dioxin-like and non-dioxin-like PHAH mixtures on thyroid
hormone and retinoid levels in plasma and liver. Both param-
eters have been suggested to be implicated in the expression of
subchronic effects such as tumor promotion and reproductive
and developmental effects. Until now, much research has been
performed on studying mainly short-term effects of individual
congeners of PCBs and dioxins on vitamin A and thyroid
TABLE 5
Thyroid Hormone Levels in Plasma of Female Sprague-Dawley Rats Following Subchronic Exposure
to Dioxin-like PHAHs (Experiment 1)
Treatment
Dose/kg bw/week
Total T3 in plasma
(nmol/l)
Total T4 in plasma
(nmol/l)
Free T4 in plasma
(pmol/l)
Total T4/free T4
(nmol/pmol)
Corn oil 1 ml 1.56 6 0.07 34.39 6 1.52a 13.75 6 0.89a 2.6 6 0.11
TCDD 1 mg 1.46 6 0.09 21.46 6 1.34b 8.80 6 0.60b 2.5 6 0.15
Aroclor 1254 7.5 mg 1.37 6 0.09 19.96 6 1.75b 12.33 6 1.07 1.6 6 0.05a,b
PHAH– 1 mg TEQ 1.40 6 0.07 15.71 6 1.22b 10.24 6 0.76 1.5 6 0.06a,b
PHAH1 0.5 mg TEQ 1.22 6 0.09 15.50 6 1.67b 8.31 6 0.93b 1.9 6 0.10a,b
PHAH1 1 mg TEQ 1.32 6 0.11 11.73 6 1.32a,b 8.14 6 0.91b 1.5 6 0.06a,b
PHAH1 2 mg TEQ 1.18 6 0.11 8.28 6 0.81a,b 7.34 6 0.64b 1.1 6 0.08a,b
Note. Data are given as arithmetic mean 6 the standard error. Doses are given per kilogram bodyweight per week.
a Significantly different from the TCDD group ( p , 0.05 Tukey HSD test).
b Significantly different from the corn oil group ( p , 0.05 Tukey HSD test).
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hormone metabolism. Here, the impact of complex PHAH
mixtures following subchronic exposure is discussed, and at-
tention is given to the contribution of strictly dioxin-like and
non-dioxin-like PCB congeners, the involvement of different
mechanisms, and the predictive value of the TEF concept.
Effects on Hepatic Retinoids
A statistically significant decrease of the retinyl palmitate
but not of the hepatic retinol levels was observed after treat-
ment with TCDD (experiment 1), the PHAH1 and the PHAH–
mixture, PCB 153, and the commercial PCB mixture Aroclor
1260. In experiment 2, TCDD decreased both hepatic retinol
and retinyl palmitate. The effects of TCDD on vitamin A status
have been extensively studied in many species and have been
shown to alter the vitamin A status in all species examined to
date (Zile, 1992). A severe decrease of hepatic vitamin A levels
was also observed after exposure to e.g., PCB 77 (Brouwer and
van den Berg, 1986; Chen et al., 1992); PCB 126 (Chen et al.,
1992; van Birgelen et al., 1994b); PCB 156 (van Birgelen et
al., 1994a); and to a lesser extent after treatment with e.g., PCB
153 (van Birgelen et al., 1992) and Aroclor 1254 (Morse and
Brouwer, 1995). The decrease of hepatic retinyl ester levels
induced by TCDD and related PHAHs may be due to a com-
bination of increased mobilization of hepatic stores of vitamin
A and inhibition of the storage of newly ingested vitamin A in
the liver (Håkansson and Ahlborg, 1985; Håkansson et al.,
1988; Kelley et al., 1998; Zile, 1992; ). TCDD was found to
severely decrease the lecithin:retinol acyltransferase (LRAT)
activity in the hepatic stellate cells (Nilsson et al., 1996), an
enzyme involved in the conversion of retinol into retinyl esters.
Increased mobilization of hepatic retinyl esters could be the
result of a direct effect of TCDD on hepatic enzyme activities
or by an up regulation of a signal controlling release of vitamin
A stores into circulation (Kelley et al., 1998; Zile, 1992).
The decrease of the hepatic retinyl palmitate concentration
appeared to be a rather sensitive effect of PHAH exposure.
Even at the lowest dose of 0.5 mg TEQ/kg bw/week of the
PHAH1 mixture, equivalent to ’70 ng TEQ/kg bw/week, a
reduction of 60% of the hepatic retinyl palmitate level was
found. In addition, the effect of the dioxin-like PHAH mixtures
appeared to be quite well predicted by the TEF concept, i.e., an
almost equal decrease of hepatic retinyl palmitate levels was
observed after treatment with TEQ equivalent doses of PHAH
mixture and TCDD (68% vs. 75%). The effect of the PHAH1
mixture on the hepatic retinoid level is within the same range
observed for the TEQ equivalent dose of the PHAH– mixture,
whereas both mixtures have a slightly, but significant, smaller
effect on the hepatic retinoid level as compared to the equipo-
tent TCDD group. The Lowest Observed Adverse Effect Level
(LOAEL) for the PHAH mixtures from this study is close to
the LOAEL of 14 ng TEQ/kg bw/day of TCDD reported by
van Birgelen et al. (1995). In contrast to the PHAH mixtures,
Aroclor 1254 (estimated dose 0.2 mg TEQ/kg bw/week) in-
duced only a slight decrease of the hepatic retinyl palmitate
level as compared to the corn oil group. A possible explanation
might be that PCB 118 and PCB 156 are the main contributors
(;60%) to the TEQ value of Aroclor 1254 (Leonards et al.,
1995), whereas for the TEQ of the PHAH mixtures these
congeners are only of minor importance (14%). Håkansson et
al. (1994) reported that PCB 118 had no effect on the hepatic
vitamin A content at dietary levels up to 2000 mg/kg. Also for
PCB 156, the loss of hepatic retinoids was shown to be a less
sensitive parameter than, for instance, reduction of plasma T4
or CYP1A2 induction (van Birgelen et al., 1994a).
Aroclor 1260 reduced the hepatic retinyl palmitate concen-
tration by 30% compared to the corn oil control, whereas its
0-4 ortho PCB fraction decreased the retinyl palmitate levels,
nonsignificantly, by 20%. The most likely explanation for this
difference in effect is the loss of impurities, i.e., PCDFs, during
the fractionation of Aroclor 1260 (Athanasiadou et al., 1991).
In fact, a slightly lower ethoxyresorufin-O-deethylase (EROD)
activity was observed after exposure to the 0-4 ortho PCB
fraction as compared to Aroclor 1260 (van der Plas et al.,
2000), which underscores the former explanation.
The effect of the 2-4 ortho PCB fraction on the hepatic
retinoid concentration was somewhat lower but close to the
effect of the di-ortho PCB 153. PCB 153 is one of the domi-
nant di-ortho congeners in environmental PHAH mixtures and
is often used as a representative for the group of 2-4 ortho
PCBs. In this study a statistically significant effect of PCB 153
on the retinoid levels in the liver was observed at the highest
dose of 9 mg/kg bw/week (’1.2 mg/kg bw/day). This is in
agreement with the results of a 13-week feeding study in
female rats, in which PCB 153 was shown to decrease the
hepatic retinoid level from 10 ppm (’0.72 mg/kg bw/day)
onwards (van Birgelen et al., 1992). As the toxicity of di-ortho
PCBs is not mediated by the Ah receptor, no TEF values are
available, and consequently risk assessment is not possible for
this category of PCBs. However, the observed effects on the
hepatic retinoid level occurred at very high doses, and it is not
likely that the non-dioxin-like PCBs will effect retinoid status
at environmental exposure levels.
Effects on Plasma Retinol
The plasma retinol level was increased after TCDD exposure
in both experiments, compared to the corn oil control. In rat, an
increase of plasma retinol after TCDD treatment has been
reported before (van Birgelen et al., 1992, 1994, 1995; Hå-
kansson et al., 1988; Kelley et al. 1998), and a similar effect
was seen after exposure to 3,39,4,49,5,59-hexachlorobiphenyl
(PCB 169) or 2,3,39,4,49,5-hexachlorobiphenyl (PCB 156)
(van Birgelen et al., 1994a; Chen et al., 1992). An increase of
the plasma retinol level after PHAH exposure may be the result
of an enhanced mobilization of hepatic vitamin A (Zile, 1992).
However, the mechanism by which hepatic mobilization of
retinol is increased is still unknown, as TCDD and related
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compounds either inhibit or have no effect on the activity of
hepatic retinyl ester hydrolase (REH) (Chen et al., 1992).
In contrast to the TCDD treatment groups, a decrease of the
plasma retinol levels was observed in the animals treated with
the PHAH mixtures and Aroclor 1254. A decrease of plasma
retinol levels was also reported after exposure to e.g., 3,39,4,49-
TCB (PCB 77); 29,3,39,4,5-PeCB (PCB 122); 3,39,4,49,5-PeCB
(PCB 126); 2,29,3,39,5,59-HxCB (PCB 133); and the commer-
cial PCB mixture Aroclor 1254 (Brouwer and van den Berg,
1986; Chen et al., 1992; Morse et al., 1996). It has been
suggested that a decrease in plasma retinol levels, as seen after
exposure to the PHAH mixtures, may be caused by a decrease
of hepatic REH activity involved in the mobilization of hepatic
vitamin A stores (Zile, 1992). However, such a decrease of
REH activity by PHAHs has not been observed before.
Another mechanistic explanation for a decrease of plasma
retinol concentrations by PHAHs has been reported by Brou-
wer et al. (1988a). The 4-hydroxy metabolite of PCB 77 was
found to displace T4 from its transport protein transthyretin
(TTR), leading to a destabilization of the RBP-TTR complex
and subsequently to a decrease in plasma retinol and thyroxin
concentrations (Brouwer and van den Berg, 1986; Brouwer et
al., 1988a). A number of other hydroxylated PHAHs were
found to possess a high binding affinity for TTR as well,
including hydroxylated PCBs likely to be formed of congeners
that are present in Aroclor 1254 and/or the PHAH mixtures,
i.e., PCB 105 (2,3,39,4,4-PeCB), 118, 126, and 156, (Bergman
et al. 1994; Brouwer et al., 1998; Lans et al., 1993, 1995a).
Disruption of plasma transport of retinol and thyroxin does not
play a role in the case of TCDD exposure, because only low
amounts of hydroxy metabolites are formed from TCDD in
vivo (Lans et al., 1995b). From the data presented here, it
became clear that there was no correlation between the expo-
sure in TEQs and the effect on plasma retinol. It is therefore
concluded that the TEF approach is not applicable to the
prediction of effects on plasma retinol levels after exposure to
complex PHAH mixtures.
Effects on Plasma Thyroid Hormone
Plasma T3 concentrations were not significantly decreased
after PHAH treatment compared to the corn oil control. How-
ever, severe reductions in both plasma TT4 and FT4 levels were
observed. This phenomenon is in accordance with other reports
on effects of PHAHs on thyroid hormones (van Birgelen et al.,
1992, 1994a,b; Lans et al., 1995a). Interestingly, the decrease
of the TT4 levels in the PHAH mixture and the Aroclor 1254
treatment groups was considerably stronger compared to the
effect observed in the TEQ equivalent TCDD group, whereas
lesser or equal effects were observed for free T4. Consequently,
in the Aroclor 1254 and the PHAH groups, the TT4/FT4 ratio
was decreased as compared to both the TCDD and the corn oil
group. This indicates a lower proportion of protein-bound T4
after exposure to Aroclor 1254 or the PHAH mixtures, which
is in line with a disturbance of the plasma protein transport
system of T4 due to T4-TTR binding competition by hydroxy-
lated PCB metabolites (Brouwer et al., 1998). Lans et al.
(1995a) demonstrated that in the blood of rats exposed to a
single dose of Aroclor 1254, the hydroxylated PCB metabolite
4-OH-2,3,39,495-PeCB competitively inhibited T4 binding to
TTR. It might be concluded that the TEF concept failed in its
prediction for the effect of PHAH exposure on the thyroid
hormone status, as the TEF concept does not account for
additional toxicity of hydroxylated PCBs as possibly observed
here.
In the PHAH1 group, the TT4/FT4 ratio was similar to the
TEQ equivalent-dosed PHAH– group, but the absolute de-
crease of the TT4 and FT4 concentrations was stronger in the
first. This is probably an indirect effect of the non-dioxin-like
PCB 153, which was added to the PHAH1 mixture. PCB 153
was shown to increase the hepatic deposition of all dioxin-like
congeners, which resulted in an increased internal exposure
(van der Plas et al., 1998, 1999) and possible enhancement of
hepatic T4 glucuronidation. A direct effect of PCB 153 on
hepatic T4 glucuronidation was considered less likely, since the
amount of PCB 153 in the PHAH mixture was below the
concentration where effects of PCB 153 on the thyroid hor-
mone status might be expected (see experiment 2; van Birgelen
et al., 1992).
In the second experiment, no statistically significant effects
on the thyroid hormone levels were observed except for a
decrease of the total T4/free T4 ratio after treatment with the
reconstituted 0-4 ortho PCB fraction and a minor, nonsignifi-
cant decrease of the total T4/free T4 ratio after treatment with
Aroclor 1260. Van der Plas et al. (2000) reported a 7- to 8-fold
increase of EROD induction after treatment with the 0-4 ortho
fraction and Aroclor 1260. Although the EROD activity ob-
served after treatment with the 0-4 ortho fraction and Aroclor
1260 is relatively low as compared to the more than 100 times
increase that can be observed after treatment with TCDD, the
CYP1A induction might be high enough to stimulate formation
of hydroxylated PCBs. Based on the exposure in TEQs of the
0-4 ortho fraction and Aroclor 1260 (see Table 1), no effects
were expected, as a NOEL of TCDD for decreasing plasma
TT4 levels was estimated on 26 ng/kg bw/day (van Birgelen et
al., 1995).
On the basis of these studies it was concluded that the effect
of complex PHAH mixtures on hepatic retinyl palmitate was
quite well predictable by the TEF concept. However, the TEF
concept failed in its prediction for the effects on plasma retinol
and underestimated the effect on plasma thyroid hormone
concentrations, possibly because the additional toxicity by
hydroxylated PCBs is not taken into account. Treatment with
the 0-4 ortho fraction at a TEQ level more than 100 times
below the NOEL for TCDD (estimated by van Birgelen et al.,
1995) still induced a significant decrease of the total T4/free T4
ratio. The non-dioxin-like PCBs did not significantly alter the
retinoid and thyroid hormone status at the dose levels tested,
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indicating that in case of exposure to these PCBs at environ-
mental levels, no effects, or at best, only marginal effects can
be expected on the retinoid and thyroid hormone status.
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